Black Diamond Therapeutics, Inc. ($BDTX)
Filing Information
| Accession Number | 0001193125-26-396868 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 21, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
7,707
Total Value
$14,874.51
P&L
+1.0% (+$154.14)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 18, 2026 | Grant/Award | 7,707 | $1.93 | $14,874.51 | 110,236 | Direct | โ | View Details |